Consonance Capital Management’s Oxford Immunotec Global OXFD Stock Holding History
Bought
Maintained
Sold
Other funds holding OXFD
ECM
Consonance Capital Management's OXFD Position: Q2 2020 in Review
Consonance Capital Management sold out of Oxford Immunotec Global (OXFD) in Q2 2020, closing a stake of 1,244,460 shares — an estimated $11.5M sold.
Consonance Capital Management first reported a position in OXFD in Q4 2017 and held it in 10 quarters. The position peaked at $44.9M in Q1 2019. 65 funds tracked by Wall St. Rank hold OXFD as of Q2 2020.
- Consonance Capital Management reported no remaining Oxford Immunotec Global position as of Q2 2020 after selling out during the quarter.
- Consonance Capital Management sold 1,244,460 Oxford Immunotec Global shares in Q2 2020, an estimated $11.5M.
- Consonance Capital Management first reported a position in Oxford Immunotec Global in Q4 2017 and held it in 10 quarters.
- Consonance Capital Management's Oxford Immunotec Global position peaked at $44.9M in Q1 2019.
- 65 funds tracked by Wall St. Rank held Oxford Immunotec Global as of Q2 2020.
Based on Consonance Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.